Core Idea - The core idea of DocGo Inc. is to create a world-class mobile health care company that delivers medical care to patients where and when it is needed, aiming for better health outcomes and reduced strain on the healthcare system [2][3]. Company Overview - DocGo Inc. is focused on building a leading provider of tech-driven mobile care, with a foundational medical transportation business that operates similarly to an Uber-like model for medical transportation [4]. - The company has a rapidly growing care in the home business, all supported by a proprietary technology backbone designed specifically for delivering care [4].

Summary of DocGo Inc. Conference Call Company Overview - **Company**: DocGo Inc. - **Industry**: Mobile healthcare - **Core Idea**: Delivering medical care to patients where and when it is needed, aiming to improve health outcomes and reduce strain on the healthcare system [2][3] Key Business Segments - **Medical Transportation**: - Tech-driven platform providing medical transportation services, akin to an Uber-like experience [3][4] - Revenue projected to exceed $200 million this year, up from less than $100 million five years ago [8] - **Care-in-the-Home**: - Rapidly growing segment providing healthcare services directly in patients' homes [3][4] - Expected to serve over 150,000 patients this year [7][15] - **Remote Patient Monitoring**: - Monitoring over 50,000 patients, primarily in cardiac care [5][12] Financial Performance - **Q3 Revenue**: Approximately $71 million, with an adjusted gross margin of 33% [10][11] - **Adjusted EBITDA Loss**: Approximately $7.2 million [10] - **Cash Position**: Total cash on the balance sheet is $95.2 million, with no debt [11] - **Growth Guidance**: Projected revenue for next year is between $280 million to $300 million, indicating significant growth potential [9][38] Market Dynamics - **Total Addressable Market (TAM)**: Significant growth expected in home healthcare delivery, with CMS predicting a shift towards home-based care [3][18] - **Chronic Disease Management**: Addressing chronic diseases, which account for 90% of the U.S. healthcare spending, is a key focus [13][14] Competitive Advantages - **Tech Integration**: Proprietary tech platform integrated with hospital systems (e.g., Epic) to streamline patient flow and improve service delivery [24][25] - **Vertical Integration**: Combining technology, clinical staff, and transportation services to provide a seamless healthcare experience [28][30] - **Strategic Partnerships**: Collaborations with major hospital systems and health insurance companies to enhance service delivery and patient engagement [4][23][27] Growth Strategy - **Expansion Plans**: Focus on increasing patient density in existing markets and expanding to new markets through existing payer relationships [36][37] - **M&A Activity**: Recent acquisition of SteadyMD to enhance telehealth capabilities and expand clinical provider network [20][21][36] - **Patient-Centric Approach**: Emphasis on keeping patients out of hospitals and managing chronic conditions effectively [31][33] Additional Insights - **Patient Engagement**: High patient satisfaction reported, leading to better health outcomes [6][12] - **Service Offerings**: Over 40 different care services provided in-home, including screenings and vaccinations [15][22] - **Market Trends**: Anticipated shift of 30% of primary care market to non-traditional providers, indicating a growing opportunity for mobile healthcare [17][18] Conclusion DocGo Inc. is positioned as a leading provider in the mobile healthcare space, leveraging technology and strategic partnerships to deliver comprehensive care solutions. The company is on a growth trajectory with a strong financial foundation and a clear strategy to address the evolving needs of the healthcare market.

Company Overview - DocGo is a leading provider of technology-enabled mobile healthcare[14] - The company delivers healthcare at any address[14] - DocGo has a proprietary technology backbone and visionary leadership team[9, 11] Financial Performance & Metrics - Total cash was $103.1 million as of March 31, 2025, up from $58.9 million on March 31, 2024[27] - Total revenue for Q1 2025 was $96.0 million[88] - Adjusted EBITDA loss for Q1 2025 was $3.9 million[87] - Adjusted gross margin for Q1 2025 was 32.1%[88] Market & Services - The total addressable market for at-home care in the U S is $265 billion[42] - The company's mobile health segment revenue for Q1 2025 was $45.2 million[88] - The company's medical transportation segment revenue for Q1 2025 was $50.8 million[88]

Financial Data and Key Metrics Changes - Total revenue for Q4 2024 was $120.8 million, a 39% decrease from $199.2 million in Q4 2023 [32] - For the full year, revenues were $616.6 million in 2024, down 1% from 2023 [34] - Net loss for Q4 2024 was $7.6 million, compared to net income of $8 million in Q4 2023 [35] - Adjusted EBITDA for Q4 2024 was $1.1 million, down from $22.6 million in Q4 2023 [35] - Adjusted EBITDA margin for the full year of 2024 was 9.8%, up from 8.6% in 2023 [36] Business Line Data and Key Metrics Changes - Mobile Health revenue for Q4 2024 was $71.8 million, down 52% from Q4 2023 [34] - Medical transportation revenue increased to $49.1 million in Q4 2024, up about 1% from Q4 2023 [34] - Transportation revenues for 2024 were 7% higher than in 2023, with a compound annual growth rate of 32% over the past three years [34] Market Data and Key Metrics Changes - The company provided services across 31 states in the U.S. and the UK, with significant expansions in New York and California [13] - The company anticipates a significant cash flow tailwind through mid-2025 from accounts receivable totaling approximately $150 million related to migrant programs [22] Company Strategy and Development Direction - The company aims to build a 100-year company that transforms healthcare delivery and brings high-quality, accessible care to all [10] - Investments are being made in technology, personnel, and infrastructure to support growth in customer verticals [11][39] - The company acquired PTI Health, a mobile phlebotomy company, to expand its service offerings [20] Management's Comments on Operating Environment and Future Outlook - Management acknowledged a near-term impact on profitability due to aggressive investments but remains optimistic about future growth opportunities [10][27] - The company expects to maintain gross margins while anticipating EBITDA margins in the mid-single digits for 2025 [46] - Management noted a robust pipeline of deals, with expectations for significant revenue growth in the base business [54][100] Other Important Information - The company received over 40,000 job applications from healthcare clinicians and corporate staff in the past year, indicating strong interest in its mission [14] - The company’s net promoter score for its care gap closure program was above 86, indicating high customer satisfaction [14] Q&A Session Summary Question: What is the 2025 revenue guidance? - Management indicated that the base business is expected to grow faster in 2025, with potential for migrant-related revenues to be below the previously estimated $50 million [50][51] Question: What are the details of the $17 million investments? - Investments are focused on technology, personnel training, and business development to support growth in the care gap closure business [58][60] Question: What was the migrant revenue in Q4 and the full year? - Migrant revenues in Q4 were approximately $55 million, with total annual revenues around $370 million [84] Question: How will the company manage unanticipated expenses? - Management noted that being self-insured introduces some uncertainty, but they are working to improve reserving practices to mitigate future fluctuations [72][75] Question: What is the outlook for the municipal business? - The company is progressing with its Project Prime initiative and expects to see contracts with existing service providers for municipal entities [121]